Nicholas A. Smith

Array ( [id] => 7243459 [patent_doc_number] => 20050271652 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Treatment of pathologies which escape the immune response, using optimised antibodies' [patent_app_type] => utility [patent_app_number] => 10/527666 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 4701 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0271/20050271652.pdf [firstpage_image] =>[orig_patent_app_number] => 10527666 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 236184 [patent_doc_number] => 07595165 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-29 [patent_title] => 'Method of measuring activation of effector cells' [patent_app_type] => utility [patent_app_number] => 10/527665 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 20 [patent_no_of_words] => 5713 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/595/07595165.pdf [firstpage_image] =>[orig_patent_app_number] => 10527665 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5912330 [patent_doc_number] => 20060127392 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-15 [patent_title] => 'Antibody for adcc and inducing cytokine production' [patent_app_type] => utility [patent_app_number] => 10/527664 [patent_app_country] => US [patent_app_date] => 2003-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4233 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20060127392.pdf [firstpage_image] =>[orig_patent_app_number] => 10527664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7467684 [patent_doc_number] => 20040053846 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Use of substances with immunomodulating activity for the treatment of amyotrophic lateral sclerosis' [patent_app_type] => new [patent_app_number] => 10/664678 [patent_app_country] => US [patent_app_date] => 2003-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2486 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053846.pdf [firstpage_image] =>[orig_patent_app_number] => 10664678 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7212411 [patent_doc_number] => 20050054117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Macrophage migration inhibitory factor as a marker for cardiovascular risk' [patent_app_type] => utility [patent_app_number] => 10/660301 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2263 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054117.pdf [firstpage_image] =>[orig_patent_app_number] => 10660301 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5834239 [patent_doc_number] => 20060246069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-02 [patent_title] => 'Human anti-human mcp-1 antibody and fragment of said antibody' [patent_app_type] => utility [patent_app_number] => 10/527823 [patent_app_country] => US [patent_app_date] => 2003-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5744 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0246/20060246069.pdf [firstpage_image] =>[orig_patent_app_number] => 10527823 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7269879 [patent_doc_number] => 20040058397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-25 [patent_title] => 'Novel antibody compositions for preparing enriched mesenchymal progenitor preparations' [patent_app_type] => new [patent_app_number] => 10/657211 [patent_app_country] => US [patent_app_date] => 2003-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8124 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0058/20040058397.pdf [firstpage_image] =>[orig_patent_app_number] => 10657211 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7082672 [patent_doc_number] => 20050048052 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Anti-CCR2 antibodies and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 10/656805 [patent_app_country] => US [patent_app_date] => 2003-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 17962 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048052.pdf [firstpage_image] =>[orig_patent_app_number] => 10656805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 449179 [patent_doc_number] => 07250491 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-07-31 [patent_title] => 'Hemolytic active proteins and genes encoding the same' [patent_app_type] => utility [patent_app_number] => 10/651250 [patent_app_country] => US [patent_app_date] => 2003-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5231 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/250/07250491.pdf [firstpage_image] =>[orig_patent_app_number] => 10651250 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7408158 [patent_doc_number] => 20040106179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof' [patent_app_type] => new [patent_app_number] => 10/644021 [patent_app_country] => US [patent_app_date] => 2003-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19491 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106179.pdf [firstpage_image] =>[orig_patent_app_number] => 10644021 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800476 [patent_doc_number] => 07425620 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'FcγRIIB-specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/643857 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 75 [patent_no_of_words] => 62511 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425620.pdf [firstpage_image] =>[orig_patent_app_number] => 10643857 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6960033 [patent_doc_number] => 20050215767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Fcgamma riib specific antibodies and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 10/524134 [patent_app_country] => US [patent_app_date] => 2003-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 59199 [patent_no_of_claims] => 107 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215767.pdf [firstpage_image] =>[orig_patent_app_number] => 10524134 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7356069 [patent_doc_number] => 20040013679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-22 [patent_title] => 'LL-37 is an immunostimulant' [patent_app_type] => new [patent_app_number] => 10/619715 [patent_app_country] => US [patent_app_date] => 2003-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6265 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0013/20040013679.pdf [firstpage_image] =>[orig_patent_app_number] => 10619715 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 196469 [patent_doc_number] => 07638326 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-29 [patent_title] => 'Activation and expansion of T-cells using an engineered multivalent signaling platform' [patent_app_type] => utility [patent_app_number] => 10/462207 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 35712 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/638/07638326.pdf [firstpage_image] =>[orig_patent_app_number] => 10462207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7463690 [patent_doc_number] => 20040101519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Activation and expansion of T-cells using an engineered multivalent signaling platform as a research tool' [patent_app_type] => new [patent_app_number] => 10/461283 [patent_app_country] => US [patent_app_date] => 2003-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 35299 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0101/20040101519.pdf [firstpage_image] =>[orig_patent_app_number] => 10461283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 884971 [patent_doc_number] => 07351803 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-04-01 [patent_title] => 'CD16A binding proteins and use for the treatment of immune disorders' [patent_app_type] => utility [patent_app_number] => 10/449566 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 20 [patent_no_of_words] => 25506 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/351/07351803.pdf [firstpage_image] =>[orig_patent_app_number] => 10449566 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6829741 [patent_doc_number] => 20030180799 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Antibodies against plasma cells' [patent_app_type] => new [patent_app_number] => 10/168809 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 16892 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180799.pdf [firstpage_image] =>[orig_patent_app_number] => 10168809 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7136707 [patent_doc_number] => 20050181457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-18 [patent_title] => 'FcyrIII signaling inhibitor assay' [patent_app_type] => utility [patent_app_number] => 10/513805 [patent_app_country] => US [patent_app_date] => 2003-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3510 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20050181457.pdf [firstpage_image] =>[orig_patent_app_number] => 10513805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6905563 [patent_doc_number] => 20050100958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-12 [patent_title] => '5T4 antigen expression' [patent_app_type] => utility [patent_app_number] => 10/434885 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22155 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20050100958.pdf [firstpage_image] =>[orig_patent_app_number] => 10434885 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7383064 [patent_doc_number] => 20040029271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Pax5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy' [patent_app_type] => new [patent_app_number] => 10/431599 [patent_app_country] => US [patent_app_date] => 2003-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9480 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029271.pdf [firstpage_image] =>[orig_patent_app_number] => 10431599 [rel_patent_id] =>[rel_patent_doc_number] =>)